Cash & equivalents decreased 32.0%
Cash & equivalents changed -32.0% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -32.0% from the comparable as-filed period.
Gross margin changed +934 basis points from the comparable as-filed period.
Gross profit changed +17.9% from the comparable as-filed period.
Net income changed +81.4% from the comparable as-filed period.
Operating income changed +70.2% from the comparable as-filed period.
Operating margin changed +922 basis points from the comparable as-filed period.
Stock-based compensation changed -179.0% from the comparable as-filed period.
Research & development changed +14.1% from the comparable as-filed period.
Inventory changed -9.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Revenue changed -6.5% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.